Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumi Goshima

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Virus Genes|June 28, 2002
Identification and characterization of the UL7 gene product of herpes simplex virus type 2Naoki Nozawa, Tohru Daikoku, Yohei Yamauchi, et al.
Virology|May 13, 2015
Roles of Epstein-Barr virus BGLF3.5 gene and two upstream open reading frames in lytic viral replication in HEK293 cellsTakahiro Watanabe, Kenshiro Fuse, Takahiro Takano, et al.
Journal of Virology|June 7, 2002
Identification and characterization of the UL56 gene product of herpes simplex virus type 2Tetsuo Koshizuka, Fumi Goshima, Hiroki Takakuwa, et al.
Archives of Virology|June 11, 2010
Apoptosis induction after herpes simplex virus infection differs according to cell type in vivoShinichi Esaki, Fumi Goshima, Sachiyo Katsumi, et al.
Virology|March 12, 2019
The BOLF1 gene is necessary for effective Epstein-Barr viral infectivityH M Abdullah Al Masud, Takahiro Watanabe, Yoshitaka Sato, et al.
Journal of Surgical Oncology|December 30, 2003
Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10Osamu Teshigahara, Fumi Goshima, Kazumasa Takao, et al.
Acta Oto-Laryngologica|August 23, 2006
Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinomaYasushi Fujimoto, Terukazu Mizuno, Saiko Sugiura, et al.
Hepato-Gastroenterology|July 9, 2003
Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex virusesHideto Kimata, Hiroki Takakuwa, Fumi Goshima, et al.
Annals of Surgical Oncology|July 26, 2006
Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancerHideto Kimata, Tsuneo Imai, Toyone Kikumori, et al.
The Journal of Investigative Dermatology|February 14, 2016
The Alarmin IL-33 Derived from HSV-2-Infected Keratinocytes Triggers Mast Cell-Mediated Antiviral Innate ImmunityRui Aoki, Tatsuyoshi Kawamura, Fumi Goshima, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Virus Genes|June 28, 2002
Identification and characterization of the UL7 gene product of herpes simplex virus type 2Naoki Nozawa, Tohru Daikoku, Yohei Yamauchi, et al.
Virology|May 13, 2015
Roles of Epstein-Barr virus BGLF3.5 gene and two upstream open reading frames in lytic viral replication in HEK293 cellsTakahiro Watanabe, Kenshiro Fuse, Takahiro Takano, et al.
Journal of Virology|June 7, 2002
Identification and characterization of the UL56 gene product of herpes simplex virus type 2Tetsuo Koshizuka, Fumi Goshima, Hiroki Takakuwa, et al.
Archives of Virology|June 11, 2010
Apoptosis induction after herpes simplex virus infection differs according to cell type in vivoShinichi Esaki, Fumi Goshima, Sachiyo Katsumi, et al.
Virology|March 12, 2019
The BOLF1 gene is necessary for effective Epstein-Barr viral infectivityH M Abdullah Al Masud, Takahiro Watanabe, Yoshitaka Sato, et al.
Journal of Surgical Oncology|December 30, 2003
Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10Osamu Teshigahara, Fumi Goshima, Kazumasa Takao, et al.
Acta Oto-Laryngologica|August 23, 2006
Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinomaYasushi Fujimoto, Terukazu Mizuno, Saiko Sugiura, et al.
Hepato-Gastroenterology|July 9, 2003
Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex virusesHideto Kimata, Hiroki Takakuwa, Fumi Goshima, et al.
Annals of Surgical Oncology|July 26, 2006
Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancerHideto Kimata, Tsuneo Imai, Toyone Kikumori, et al.
The Journal of Investigative Dermatology|February 14, 2016
The Alarmin IL-33 Derived from HSV-2-Infected Keratinocytes Triggers Mast Cell-Mediated Antiviral Innate ImmunityRui Aoki, Tatsuyoshi Kawamura, Fumi Goshima, et al.
Pageof 9